JP2018513124A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513124A5 JP2018513124A5 JP2017548053A JP2017548053A JP2018513124A5 JP 2018513124 A5 JP2018513124 A5 JP 2018513124A5 JP 2017548053 A JP2017548053 A JP 2017548053A JP 2017548053 A JP2017548053 A JP 2017548053A JP 2018513124 A5 JP2018513124 A5 JP 2018513124A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- comprises seq
- loop comprises
- seq
- loop
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021061713A JP7320550B2 (ja) | 2015-03-12 | 2021-03-31 | アルブミン融合タンパク質を精製する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562132198P | 2015-03-12 | 2015-03-12 | |
| US62/132,198 | 2015-03-12 | ||
| PCT/US2016/022003 WO2016145307A1 (en) | 2015-03-12 | 2016-03-11 | Method of purifying albumin-fusion proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021061713A Division JP7320550B2 (ja) | 2015-03-12 | 2021-03-31 | アルブミン融合タンパク質を精製する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018513124A JP2018513124A (ja) | 2018-05-24 |
| JP2018513124A5 true JP2018513124A5 (enExample) | 2019-04-18 |
| JP6862348B2 JP6862348B2 (ja) | 2021-04-21 |
Family
ID=56878920
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017548053A Active JP6862348B2 (ja) | 2015-03-12 | 2016-03-11 | アルブミン融合タンパク質を精製する方法 |
| JP2021061713A Active JP7320550B2 (ja) | 2015-03-12 | 2021-03-31 | アルブミン融合タンパク質を精製する方法 |
| JP2023080507A Active JP7826243B2 (ja) | 2015-03-12 | 2023-05-16 | アルブミン融合タンパク質を精製する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021061713A Active JP7320550B2 (ja) | 2015-03-12 | 2021-03-31 | アルブミン融合タンパク質を精製する方法 |
| JP2023080507A Active JP7826243B2 (ja) | 2015-03-12 | 2023-05-16 | アルブミン融合タンパク質を精製する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10683340B2 (enExample) |
| EP (2) | EP3268389B1 (enExample) |
| JP (3) | JP6862348B2 (enExample) |
| KR (2) | KR20170124592A (enExample) |
| CN (1) | CN107428817B (enExample) |
| AU (4) | AU2016228806B2 (enExample) |
| CA (2) | CA3260163A1 (enExample) |
| ES (1) | ES2839211T3 (enExample) |
| IL (1) | IL253971B (enExample) |
| WO (1) | WO2016145307A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3753567A1 (en) | 2011-10-11 | 2020-12-23 | Viela Bio, Inc. | Cd40l-specific tn3-derived scaffolds and methods of use thereof |
| ES2991988T3 (es) | 2017-10-30 | 2024-12-05 | Takeda Pharmaceuticals Co | Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica |
| EA202092778A1 (ru) | 2018-05-16 | 2021-05-27 | ЛИБ ТЕРАПЬЮТИКС, ЭлЭлСи | Композиции, содержащие pcsk9-связывающие молекулы, и способы применения |
| CN113286806A (zh) * | 2018-11-09 | 2021-08-20 | 尼欧派普制药有限两合公司 | 治疗压力、免疫反应和中风综合征的多肽 |
| EP3711772A1 (en) | 2019-03-20 | 2020-09-23 | Oslo Universitetssykehus HF | Recombinant proteins and fusion proteins |
| CN110295152A (zh) * | 2019-07-29 | 2019-10-01 | 北京泓恩生物科技有限公司 | 一种重组产朊假丝酵母尿酸酶的纯化方法 |
| SG11202110968VA (en) | 2019-12-06 | 2021-10-28 | Regeneron Pharma | Anti-vegf protein compositions and methods for producing the same |
| AU2021268026A1 (en) | 2020-05-08 | 2023-01-19 | Regeneron Pharmaceuticals, Inc. | VEGF traps and mini-traps and methods for treating ocular disorders and cancer |
| JP2023532544A (ja) * | 2020-07-01 | 2023-07-28 | メディミューン，エルエルシー | 生物学的製剤を精製するための洗浄剤及び方法 |
| CN112062833A (zh) * | 2020-10-09 | 2020-12-11 | 国药集团武汉血液制品有限公司 | 一种从血浆组分ⅳ沉淀中提取人血白蛋白的方法 |
| CN115677848A (zh) * | 2022-10-24 | 2023-02-03 | 通化安睿特生物制药股份有限公司 | 一种制备高纯度高稳定性蛋白质的方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| CA2079802C (en) | 1990-04-05 | 2001-09-18 | Roberto Crea | Walk-through mutagenesis |
| US7063943B1 (en) | 1990-07-10 | 2006-06-20 | Cambridge Antibody Technology | Methods for producing members of specific binding pairs |
| US5843701A (en) | 1990-08-02 | 1998-12-01 | Nexstar Pharmaceticals, Inc. | Systematic polypeptide evolution by reverse translation |
| US5866344A (en) | 1991-11-15 | 1999-02-02 | Board Of Regents, The University Of Texas System | Antibody selection methods using cell surface expressed libraries |
| FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US5440018A (en) * | 1992-05-20 | 1995-08-08 | The Green Cross Corporation | Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| US5922545A (en) | 1993-10-29 | 1999-07-13 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6699658B1 (en) | 1996-05-31 | 2004-03-02 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| EP1958962A3 (en) | 1997-06-12 | 2013-05-01 | Novartis International Pharmaceutical Ltd. | Artificial antibody polypeptides |
| NZ511699A (en) | 1998-12-02 | 2003-02-28 | Phylos Inc | DNA-protein fusions and uses thereof |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| DK1196637T3 (da) | 1999-07-27 | 2007-07-30 | Adnexus Therapeutics Inc | Peptidacceptor-ligeringsmetoder |
| US7022479B2 (en) | 2000-01-24 | 2006-04-04 | Compound Therapeutics, Inc. | Sensitive, multiplexed diagnostic assays for protein analysis |
| AU2002310502A1 (en) | 2001-06-21 | 2003-01-08 | Phylos, Inc. | In vitro protein interaction detection systems |
| KR100524872B1 (ko) * | 2003-12-04 | 2005-11-01 | 씨제이 주식회사 | 인터페론 베타의 정제방법 |
| CA2572917C (en) | 2004-07-06 | 2012-04-03 | Bioren Inc. | Look-through mutagenesis for developing altered polypeptides with enhanced properties |
| CN101384623B (zh) | 2005-12-22 | 2013-07-24 | 常山凯捷健生物药物研发（河北）有限公司 | 白蛋白与治疗剂的预成型偶联物的制备方法 |
| KR101610791B1 (ko) | 2007-07-03 | 2016-04-11 | 다누타 크루셰프스카 | 알파케토글루타레이트의 의약 용도 |
| WO2009023184A2 (en) | 2007-08-10 | 2009-02-19 | Protelix, Inc. | Universal fibronectin type iii binding-domain libraries |
| US8633297B2 (en) | 2007-10-31 | 2014-01-21 | Medimmune, Llc | Protein scaffolds |
| ES2705714T3 (es) | 2008-10-31 | 2019-03-26 | Janssen Biotech Inc | Métodos y usos de dominio de Fibronectina tipo III basado en estructuras de composiciones |
| BRPI1008532B1 (pt) | 2009-02-12 | 2021-12-14 | Janssen Biotech, Inc | Arcabouço de proteína isolada, método para construção de uma biblioteca de arcabouço de proteína isolada, molécula de ácido nucleico isolada, vetor de ácido nucleico isolado, célula hospedeira de bactéria ou fungo, composição, dispositivo médico e artigo de manufatura para uso farmacêutico ou de diagnóstico em seres humanos |
| DK2427486T3 (en) | 2009-05-07 | 2015-05-26 | Novozymes Biopharma Dk As | A process for purifying albumin |
| EP2493921B1 (en) | 2009-10-30 | 2018-09-26 | Albumedix Ltd | Albumin variants |
| KR20130020765A (ko) | 2010-02-16 | 2013-02-28 | 메디뮨 엘엘씨 | Ｈｓａ-관련 조성물 및 사용방법 |
| WO2011130324A1 (en) | 2010-04-13 | 2011-10-20 | Medimmune, Llc | Fibronectin type iii domain-based multimeric scaffolds |
| CN103379915A (zh) | 2011-02-15 | 2013-10-30 | 米迪缪尼有限公司 | Hsa相关组合物及使用方法 |
| EP3753567A1 (en) | 2011-10-11 | 2020-12-23 | Viela Bio, Inc. | Cd40l-specific tn3-derived scaffolds and methods of use thereof |
| MX2015005363A (es) * | 2012-11-08 | 2015-11-06 | Novozymes Biopharma Dk As | Variantes de albumina. |
-
2016
- 2016-03-11 AU AU2016228806A patent/AU2016228806B2/en active Active
- 2016-03-11 EP EP16762595.3A patent/EP3268389B1/en active Active
- 2016-03-11 KR KR1020177028780A patent/KR20170124592A/ko not_active Ceased
- 2016-03-11 CA CA3260163A patent/CA3260163A1/en active Pending
- 2016-03-11 ES ES16762595T patent/ES2839211T3/es active Active
- 2016-03-11 KR KR1020247016329A patent/KR20240093725A/ko active Pending
- 2016-03-11 CA CA2977675A patent/CA2977675A1/en active Pending
- 2016-03-11 CN CN201680014597.2A patent/CN107428817B/zh active Active
- 2016-03-11 WO PCT/US2016/022003 patent/WO2016145307A1/en not_active Ceased
- 2016-03-11 US US15/557,358 patent/US10683340B2/en active Active
- 2016-03-11 EP EP20198757.5A patent/EP3842451A1/en active Pending
- 2016-03-11 JP JP2017548053A patent/JP6862348B2/ja active Active
-
2017
- 2017-08-14 IL IL253971A patent/IL253971B/en unknown
-
2020
- 2020-06-15 US US16/901,812 patent/US11548933B2/en active Active
-
2021
- 2021-01-22 AU AU2021200423A patent/AU2021200423B2/en active Active
- 2021-03-31 JP JP2021061713A patent/JP7320550B2/ja active Active
-
2023
- 2023-01-06 US US18/150,983 patent/US20230340074A1/en active Pending
- 2023-05-16 JP JP2023080507A patent/JP7826243B2/ja active Active
- 2023-07-03 AU AU2023204271A patent/AU2023204271B2/en active Active
-
2026
- 2026-03-13 AU AU2026201911A patent/AU2026201911A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018513124A5 (enExample) | ||
| EP2691411B1 (en) | Buffer system for protein purification | |
| JP7094322B2 (ja) | カプリル酸を用いてタンパク質を精製する方法 | |
| JP7320550B2 (ja) | アルブミン融合タンパク質を精製する方法 | |
| CA2784278C (en) | Wash solution and method for affinity chromatography | |
| JP5596078B2 (ja) | 高アニオン性タンパク質の精製方法 | |
| JP2021508484A5 (enExample) | ||
| JPWO2020209318A5 (enExample) | ||
| CN103596968A (zh) | 用于亲和层析的洗涤溶液和方法 | |
| JP2003530326A (ja) | ＩｇＧを製造する方法 | |
| EP3060578A1 (en) | Antibody purification | |
| JPH08512323A (ja) | タンパク精製方法 | |
| JP4288153B2 (ja) | 非常に陰イオン性であるタンパク質を精製する方法 | |
| JP2024539136A (ja) | ＩｇＧ Ｆｃドメインを有する融合タンパク質の精製方法 | |
| JP4060123B2 (ja) | タンパク質の失活を抑制する方法 | |
| RU2020124946A (ru) | Способы очистки аденоассоциированных вирусов | |
| JPH04108799A (ja) | 血液凝固第８因子結合性ペプチド及びその使用 |